Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036283 | PMC |
| http://dx.doi.org/10.1186/s13054-016-1473-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Angiotensin II-Real-Life Use and Literature Review.
Medicina (Kaunas)
September 2024
Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia.
Article Synopsis
- Angiotensin II, a vasopressor introduced in 2017, induces vasoconstriction by activating the renin-angiotensin-aldosterone system, but high costs limit its use.
- It's particularly effective for treating vasoplegic and cardiogenic shock in patients unresponsive to other treatments like catecholamines and vasopressin.
- Despite its benefits, there's limited data on the best timing for administration and how to use it alongside other vasopressors, prompting ongoing studies to fill these knowledge gaps.
Rhinitis Control and Medication Use in a Real-World Sample of Patients With Persistent Rhinitis or Rhinosinusitis: A Community Pharmacy Study.
J Allergy Clin Immunol Pract
July 2024
Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium. Electronic address:
Background: Little is known about rhinitis control in real-life, nor about the contribution of treatment-related and patient-related factors.
Objective: This study aimed to examine the level of rhinitis control and rhinitis medication utilization in patients with persistent rhinitis and to identify predictors of rhinitis control.
Methods: A cross-sectional observational study was conducted in patients with persistent rhinitis recruited in community pharmacies.
A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold.
Ther Adv Respir Dis
February 2024
Haleon CH SARL, Nyon, Switzerland.
Background: The common cold is a frequent, acute, and mild upper respiratory human disease. Nasal congestion has been considered the most bothersome symptom in the common cold, impacting quality of life (QoL). Topical decongestants containing steroids benefit QoL in allergic rhinitis, but no published research has assessed the impact of topical decongestants on QoL in the common cold.
View Article and Find Full Text PDFImpact of Student Pharmacist State Anxiety on Vasopressor Calculation Accuracy in Advanced Cardiac Life Support Simulations.
Am J Pharm Educ
March 2024
Department of Pharmacy Practice, Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, PA, USA.
Objective: To assess the impact of student pharmacist state anxiety on vasopressor calculation accuracy in advanced cardiac life support (ACLS) simulations.
Methods: Third-year professional students participated in 2 ACLS-related simulation laboratory sessions. In week 1, students completed 3 calculations at their workstation with no stressors.
Real-Life Adherence to Venom Immunotherapy and Adrenaline Autoinjector.
Int Arch Allergy Immunol
March 2024
Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.
Introduction: Venom immunotherapy (VIT) and adrenaline autoinjector (AAI) are important therapies in venom anaphylaxis. Adherence to VIT and AAI in patients with venom allergy has been evaluated in a few studies; however, solid data are lacking. This study aimed to evaluate VIT and AAI retrieval rates in patients with venom allergy with a special focus on adherence to treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!